Cargando…
Extrapulmonary Clinical Manifestations in COVID-19 Patients
COVID-19 manifestations in symptomatic patients can be in the form of pneumonia, acute respiratory syndrome, and multiple organ dysfunction as well. Renal complications, gastrointestinal dysfunctions, endocrine system disorders, myocardial dysfunction and arrhythmia, neurological dysfunctions, derma...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646754/ https://www.ncbi.nlm.nih.gov/pubmed/32940201 http://dx.doi.org/10.4269/ajtmh.20-0986 |
_version_ | 1783606845668065280 |
---|---|
author | Sarkesh, Aila Daei Sorkhabi, Amin Sheykhsaran, Elham Alinezhad, Farbod Mohammadzadeh, Nader Hemmat, Nima Bannazadeh Baghi, Hossein |
author_facet | Sarkesh, Aila Daei Sorkhabi, Amin Sheykhsaran, Elham Alinezhad, Farbod Mohammadzadeh, Nader Hemmat, Nima Bannazadeh Baghi, Hossein |
author_sort | Sarkesh, Aila |
collection | PubMed |
description | COVID-19 manifestations in symptomatic patients can be in the form of pneumonia, acute respiratory syndrome, and multiple organ dysfunction as well. Renal complications, gastrointestinal dysfunctions, endocrine system disorders, myocardial dysfunction and arrhythmia, neurological dysfunctions, dermatological symptoms, hematological manifestations, and thromboinflammation are among the reported extrapulmonary complications. Moreover, the presence of coagulopathy, excessive and dysregulated immune responses, and autoimmunity by COVID-19 patients is considerable. The pathogenesis of infection entails the entry of the virus via receptors on cells, principally angiotensin-converting enzyme 2 receptors. Direct virus damage coupled with indirect effects of viral infection including thromboinflammation, dysfunction of the immune system, and dysregulation of the renin–angiotensin system leads to multiple organ failure. This review outlines the extrapulmonary organ–specific complications and their pathophysiology and epidemiology. |
format | Online Article Text |
id | pubmed-7646754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The American Society of Tropical Medicine and Hygiene |
record_format | MEDLINE/PubMed |
spelling | pubmed-76467542020-11-17 Extrapulmonary Clinical Manifestations in COVID-19 Patients Sarkesh, Aila Daei Sorkhabi, Amin Sheykhsaran, Elham Alinezhad, Farbod Mohammadzadeh, Nader Hemmat, Nima Bannazadeh Baghi, Hossein Am J Trop Med Hyg Review Article COVID-19 manifestations in symptomatic patients can be in the form of pneumonia, acute respiratory syndrome, and multiple organ dysfunction as well. Renal complications, gastrointestinal dysfunctions, endocrine system disorders, myocardial dysfunction and arrhythmia, neurological dysfunctions, dermatological symptoms, hematological manifestations, and thromboinflammation are among the reported extrapulmonary complications. Moreover, the presence of coagulopathy, excessive and dysregulated immune responses, and autoimmunity by COVID-19 patients is considerable. The pathogenesis of infection entails the entry of the virus via receptors on cells, principally angiotensin-converting enzyme 2 receptors. Direct virus damage coupled with indirect effects of viral infection including thromboinflammation, dysfunction of the immune system, and dysregulation of the renin–angiotensin system leads to multiple organ failure. This review outlines the extrapulmonary organ–specific complications and their pathophysiology and epidemiology. The American Society of Tropical Medicine and Hygiene 2020-11 2020-09-15 /pmc/articles/PMC7646754/ /pubmed/32940201 http://dx.doi.org/10.4269/ajtmh.20-0986 Text en © The American Society of Tropical Medicine and Hygiene This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Article Sarkesh, Aila Daei Sorkhabi, Amin Sheykhsaran, Elham Alinezhad, Farbod Mohammadzadeh, Nader Hemmat, Nima Bannazadeh Baghi, Hossein Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title | Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title_full | Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title_fullStr | Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title_full_unstemmed | Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title_short | Extrapulmonary Clinical Manifestations in COVID-19 Patients |
title_sort | extrapulmonary clinical manifestations in covid-19 patients |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646754/ https://www.ncbi.nlm.nih.gov/pubmed/32940201 http://dx.doi.org/10.4269/ajtmh.20-0986 |
work_keys_str_mv | AT sarkeshaila extrapulmonaryclinicalmanifestationsincovid19patients AT daeisorkhabiamin extrapulmonaryclinicalmanifestationsincovid19patients AT sheykhsaranelham extrapulmonaryclinicalmanifestationsincovid19patients AT alinezhadfarbod extrapulmonaryclinicalmanifestationsincovid19patients AT mohammadzadehnader extrapulmonaryclinicalmanifestationsincovid19patients AT hemmatnima extrapulmonaryclinicalmanifestationsincovid19patients AT bannazadehbaghihossein extrapulmonaryclinicalmanifestationsincovid19patients |